| Mrs Laura L Baehnman, APNP | |
|
N2934 State Road 22, Wautoma, WI 54982-5267 | |
| (920) 787-4613 | |
| (920) 787-5433 |
| Full Name | Mrs Laura L Baehnman |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 14 Years |
| Location | N2934 State Road 22, Wautoma, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700195567 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SM0705X | Clinical Nurse Specialist - Medical-surgical | 4203-33 (Wisconsin) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 4203 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thedacare Regional Med Ctr - Neenah | Neenah, WI | Hospital |
| Berlin Memorial Hospital | Berlin, WI | Hospital |
| Thedacare Medical Center - Wild Rose | Wild rose, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thedacare Incorporated | 1759294887 | 493 |
News Archive
The American Academy of Dermatology Association (AADA) recently updated its position statement on the use of isotretinoin. The position continues to state that patient safety is dermatologists' primary concern and that the AADA is committed to the safe and responsible use of isotretinoin, which is the most effective treatment for severe acne.
Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced the Company has signed a license agreement with the University of Toronto for novel anti-KIT receptor tyrosine kinase antibodies identified in the laboratories of Dr. Sachdev Sidhu at the University of Toronto and the laboratory of Dr. Joseph Schlessinger of Yale University.
Researchers at Tsinghua University, Beijing, have conducted a study providing possible new insights into the evolution and cross-species transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
BioDelivery Sciences International, Inc. (Nasdaq: BDSI), today announced the consolidation of the company's laboratory and other operations in Newark, New Jersey to the company's headquarters in Raleigh, North Carolina. BDSI will vacate its Newark facility by September 30, 2009.
More patients could be eligible for critical treatments to remove or dissolve blood clots that cause strokes, according to a new treatment guideline issued by the American Heart Association/American Stroke Association.
› Verified 1 days ago
| Entity Name | Thedacare Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376656959 PECOS PAC ID: 1759294887 Enrollment ID: O20031106000088 |
News Archive
The American Academy of Dermatology Association (AADA) recently updated its position statement on the use of isotretinoin. The position continues to state that patient safety is dermatologists' primary concern and that the AADA is committed to the safe and responsible use of isotretinoin, which is the most effective treatment for severe acne.
Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced the Company has signed a license agreement with the University of Toronto for novel anti-KIT receptor tyrosine kinase antibodies identified in the laboratories of Dr. Sachdev Sidhu at the University of Toronto and the laboratory of Dr. Joseph Schlessinger of Yale University.
Researchers at Tsinghua University, Beijing, have conducted a study providing possible new insights into the evolution and cross-species transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
BioDelivery Sciences International, Inc. (Nasdaq: BDSI), today announced the consolidation of the company's laboratory and other operations in Newark, New Jersey to the company's headquarters in Raleigh, North Carolina. BDSI will vacate its Newark facility by September 30, 2009.
More patients could be eligible for critical treatments to remove or dissolve blood clots that cause strokes, according to a new treatment guideline issued by the American Heart Association/American Stroke Association.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Laura L Baehnman, APNP 100 Theda Clark Medical Plz Ste 400, Neenah, WI 54956-2763 Ph: (920) 725-4527 | Mrs Laura L Baehnman, APNP N2934 State Road 22, Wautoma, WI 54982-5267 Ph: (920) 787-4613 |
News Archive
The American Academy of Dermatology Association (AADA) recently updated its position statement on the use of isotretinoin. The position continues to state that patient safety is dermatologists' primary concern and that the AADA is committed to the safe and responsible use of isotretinoin, which is the most effective treatment for severe acne.
Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced the Company has signed a license agreement with the University of Toronto for novel anti-KIT receptor tyrosine kinase antibodies identified in the laboratories of Dr. Sachdev Sidhu at the University of Toronto and the laboratory of Dr. Joseph Schlessinger of Yale University.
Researchers at Tsinghua University, Beijing, have conducted a study providing possible new insights into the evolution and cross-species transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.
BioDelivery Sciences International, Inc. (Nasdaq: BDSI), today announced the consolidation of the company's laboratory and other operations in Newark, New Jersey to the company's headquarters in Raleigh, North Carolina. BDSI will vacate its Newark facility by September 30, 2009.
More patients could be eligible for critical treatments to remove or dissolve blood clots that cause strokes, according to a new treatment guideline issued by the American Heart Association/American Stroke Association.
› Verified 1 days ago
Amy Schoenoff, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 400 S Townline Rd, Wautoma, WI 54982 Phone: 920-787-5514 Fax: 920-787-4737 | |
Paige Dorsey, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 400 S Townline Rd, Wautoma, WI 54982 Phone: 920-787-5514 Fax: 920-787-4737 | |
Jennilee Hill, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 S. Townline Rd, Wautoma, WI 54982 Phone: 920-787-5514 Fax: 920-787-4737 | |
Lindsay M Lyle, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 900 E Division St, Wautoma, WI 54982 Phone: 920-787-6900 | |
Kera Schill, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 230 W Park St, Wautoma, WI 54982 Phone: 920-787-6590 | |
Lisa Ann Ladwig, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 400 S Townline Rd, Wautoma, WI 54982 Phone: 800-942-5330 | |
Heather Jean Greiling, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 900 E Division St, Wautoma, WI 54982 Phone: 920-787-6900 |